Tenet Healthcare (THC) Stock Forecast & Price Target

Compare

890 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

THC Analyst Ratings

Strong Buy

15 Buy

2 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Tenet

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

THC Stock 12 Month Forecast

Average Price Target

$196.35

▲(32.33%Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $196.35 with a high forecast of $238.00 and a low forecast of $154.00. The average price target represents a 32.33% change from the last price of $148.38.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"125":"$125","182":"$182","239":"$239","153.5":"$153.5","210.5":"$210.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":238,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$238.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":196.35,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$196.35</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":154,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$154.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[125,153.5,182,210.5,239],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.43,182.08923076923077,186.74846153846156,191.40769230769232,196.06692307692308,200.72615384615386,205.38538461538462,210.04461538461538,214.70384615384614,219.36307692307693,224.0223076923077,228.68153846153848,233.34076923076924,{"y":238,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.43,178.88538461538462,180.34076923076924,181.79615384615386,183.25153846153847,184.7069230769231,186.1623076923077,187.6176923076923,189.0730769230769,190.52846153846153,191.98384615384614,193.43923076923076,194.89461538461538,{"y":196.35,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,177.43,175.6276923076923,173.82538461538462,172.02307692307693,170.22076923076924,168.41846153846154,166.61615384615385,164.81384615384616,163.01153846153846,161.20923076923077,159.40692307692308,157.60461538461539,155.8023076923077,{"y":154,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":133.3,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.84,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.87,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.13,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.03,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.23,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.89,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.12,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.43,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$238.00

Average Price Target$196.35

Lowest Price Target$154.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$161

Hold

8.51%

Upside

Downgraded

07/25/25

The overall score reflects strong earnings call results and undervaluation, offset by bearish technical indicators and financial risks from high leverage and declining profitability. Positive corporate events provide a minor boost.

Michael HaRobert W. Baird

Robert W. Baird

$195→$167

Hold

12.55%

Upside

Reiterated

07/25/25

Tenet Healthcare price target lowered to $167 from $195 at BairdTenet Healthcare price target lowered to $167 from $195 at Baird

Whit MayoLeerink Partners

Leerink Partners

$209→$213

Buy

43.55%

Upside

Reiterated

07/24/25

Tenet Healthcare's Strong Financial Performance and Strategic Initiatives Drive Buy Rating

Andrew Mok CFABarclays

Barclays

$215→$208

Buy

40.18%

Upside

Reiterated

07/24/25

Tenet Healthcare (THC) Gets a Buy from Barclays

John RansomRaymond James

Raymond James

$200

Buy

34.79%

Upside

Reiterated

07/23/25

Raymond James Remains a Buy on Tenet Healthcare (THC)

A.J. RiceUBS

UBS

$230→$238

Buy

60.40%

Upside

Reiterated

07/23/25

Tenet Healthcare price target raised to $238 from $230 at UBSTenet Healthcare price target raised to $238 from $230 at UBS

David S MacdonaldTruist Financial

Truist Financial

$205

Buy

38.16%

Upside

Reiterated

07/23/25

Truist Financial Keeps Their Buy Rating on Tenet Healthcare (THC)

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$177→$190

Buy

28.05%

Upside

Reiterated

07/23/25

Cantor Fitzgerald Reaffirms Their Buy Rating on Tenet Healthcare (THC)Cantor Fitzgerald analyst Sarah James raised the price target on Tenet Healthcare (NYSE: THC) to $190.00 (from $177.00) while maintaining a Overweight rating.

Craig HettenbachMorgan Stanley

Morgan Stanley

$210→$225

Buy

51.64%

Upside

Reiterated

07/23/25

Tenet Healthcare: Strategic Focus and Financial Performance Drive Buy Rating

Jason CassorlaGuggenheim

Guggenheim

$180→$188

Buy

26.70%

Upside

Reiterated

07/23/25

Tenet Healthcare price target raised to $188 from $180 at GuggenheimTenet Healthcare price target raised to $188 from $180 at Guggenheim

Kevin FischbeckBank of America Securities

Bank of America Securities

$195→$205

Buy

38.16%

Upside

Reiterated

07/22/25

Strong Performance and Strategic Growth Drive Buy Rating for Tenet Healthcare

Ben HendrixRBC Capital

RBC Capital

$189

Buy

27.38%

Upside

Reiterated

07/22/25

RBC Capital Keeps Their Buy Rating on Tenet Healthcare (THC)

Stephen BaxterWells Fargo

Wells Fargo

$195

Buy

31.42%

Upside

Reiterated

07/22/25

Wells says commentary on Tenet Healthcare earnings call 'generally as expected'Wells says commentary on Tenet Healthcare earnings call 'generally as expected'

Ryan LangstonTD Cowen

TD Cowen

$175→$192

Buy

29.40%

Upside

Reiterated

07/22/25

Strong Financial Performance and Strategic Positioning Support Buy Rating for Tenet Healthcare

Ann HynesMizuho Securities

Mizuho Securities

$184→$194

Buy

30.75%

Upside

Reiterated

07/11/25

Tenet Healthcare price target raised to $194 from $184 at MizuhoTenet Healthcare price target raised to $194 from $184 at Mizuho

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$161

Hold

8.51%

Upside

Downgraded

07/25/25

Michael HaRobert W. Baird

Robert W. Baird

$195→$167

Hold

12.55%

Upside

Reiterated

07/25/25

Tenet Healthcare price target lowered to $167 from $195 at BairdTenet Healthcare price target lowered to $167 from $195 at Baird

Whit MayoLeerink Partners

Leerink Partners

$209→$213

Buy

43.55%

Upside

Reiterated

07/24/25

Tenet Healthcare's Strong Financial Performance and Strategic Initiatives Drive Buy Rating

Andrew Mok CFABarclays

Barclays

$215→$208

Buy

40.18%

Upside

Reiterated

07/24/25

Tenet Healthcare (THC) Gets a Buy from Barclays

John RansomRaymond James

Raymond James

$200

Buy

34.79%

Upside

Reiterated

07/23/25

Raymond James Remains a Buy on Tenet Healthcare (THC)

A.J. RiceUBS

UBS

$230→$238

Buy

60.40%

Upside

Reiterated

07/23/25

Tenet Healthcare price target raised to $238 from $230 at UBSTenet Healthcare price target raised to $238 from $230 at UBS

David S MacdonaldTruist Financial

Truist Financial

$205

Buy

38.16%

Upside

Reiterated

07/23/25

Truist Financial Keeps Their Buy Rating on Tenet Healthcare (THC)

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$177→$190

Buy

28.05%

Upside

Reiterated

07/23/25

Craig HettenbachMorgan Stanley

Morgan Stanley

$210→$225

Buy

51.64%

Upside

Reiterated

07/23/25

Tenet Healthcare: Strategic Focus and Financial Performance Drive Buy Rating

Jason CassorlaGuggenheim

Guggenheim

$180→$188

Buy

26.70%

Upside

Reiterated

07/23/25

Tenet Healthcare price target raised to $188 from $180 at GuggenheimTenet Healthcare price target raised to $188 from $180 at Guggenheim

Kevin FischbeckBank of America Securities

Bank of America Securities

$195→$205

Buy

38.16%

Upside

Reiterated

07/22/25

Strong Performance and Strategic Growth Drive Buy Rating for Tenet Healthcare

Ben HendrixRBC Capital

RBC Capital

$189

Buy

27.38%

Upside

Reiterated

07/22/25

RBC Capital Keeps Their Buy Rating on Tenet Healthcare (THC)

Stephen BaxterWells Fargo

Wells Fargo

$195

Buy

31.42%

Upside

Reiterated

07/22/25

Wells says commentary on Tenet Healthcare earnings call 'generally as expected'Wells says commentary on Tenet Healthcare earnings call 'generally as expected'

Ryan LangstonTD Cowen

TD Cowen

$175→$192

Buy

29.40%

Upside

Reiterated

07/22/25

Strong Financial Performance and Strategic Positioning Support Buy Rating for Tenet Healthcare

Ann HynesMizuho Securities

Mizuho Securities

$184→$194

Buy

30.75%

Upside

Reiterated

07/11/25

Tenet Healthcare price target raised to $194 from $184 at MizuhoTenet Healthcare price target raised to $194 from $184 at Mizuho

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

1 Month

xxx

Success Rate

17/22 ratings generated profit

Average Return

+7.74%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 77.27% of your transactions generating a profit, with an average return of +7.74% per trade.

3 Months

xxx

Success Rate

17/25 ratings generated profit

Average Return

+15.95%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 68.00% of your transactions generating a profit, with an average return of +15.95% per trade.

1 Year

David S MacdonaldTruist Financial

Success Rate

17/22 ratings generated profit

Average Return

+26.97%

reiterated a buy rating 3 days ago

Copying David S Macdonald's trades and holding each position for 1 Year would result in 77.27% of your transactions generating a profit, with an average return of +26.97% per trade.

2 Years

xxx

Success Rate

19/22 ratings generated profit

Average Return

+62.31%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 86.36% of your transactions generating a profit, with an average return of +62.31% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, THC has received 34 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. THC average Analyst price target in the past 3 months is 196.35.

Each month's total comprises the sum of three months' worth of ratings.

THC Financial Forecast

THC Earnings Forecast

Next quarter’s earnings estimate for THC is $3.21 with a range of $2.53 to $3.60. The previous quarter’s EPS was $4.02. THC beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.99% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.

THC Sales Forecast

Next quarter’s sales forecast for THC is $5.25B with a range of $5.11B to $5.35B. The previous quarter’s sales results were $5.27B. THC beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.

THC Stock Forecast FAQ

What is THC’s average 12-month price target, according to analysts?

Based on analyst ratings, Tenet Healthcare Corp.’s 12-month average price target is 196.35.

What is THC’s upside potential, based on the analysts’ average price target?

Tenet Healthcare Corp. has 32.33% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is THC a Buy, Sell or Hold?

Tenet Healthcare Corp. has a consensus rating of Strong Buy which is based on 15 buy ratings, 2 hold ratings and 0 sell ratings.

What is Tenet Healthcare Corp.’s price target?

The average price target for Tenet Healthcare Corp. is 196.35. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $238.00 ,the lowest forecast is $154.00. The average price target represents 32.33% Increase from the current price of $148.38.

What do analysts say about Tenet Healthcare Corp.?

Tenet Healthcare Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of THC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Tenet Healthcare (THC) Stock Forecast & Price Target

THC Analyst Ratings

THC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Tenet Healthcare

THC Analyst Recommendation Trends

THC Financial Forecast

THC Earnings Forecast

THC Sales Forecast

THC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts